Navigation Links
SGX Pharmaceuticals to Present at Two Upcoming Investor Conferences
Date:2/6/2008

SAN DIEGO, Feb. 6 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals, Inc. (Nasdaq: SGXP) announced today that the Company will be presenting at two upcoming investor conferences. The conference information is as follows:

-- 10th Annual BIO CEO & Investor Conference: Wednesday, February 13, 2008

at 1:15 PM Eastern Standard Time at the Waldorf=Astoria, New York City.

-- Roth 20th Annual OC Growth Stock Conference: Tuesday, February 19, 2008

at 11:30 AM Pacific Standard Time at the Ritz Carlton Laguna Niguel,

California.

A live webcast of both presentations will be available under the investor relations section of the Company's website at http://www.sgxpharma.com. Replays of the presentation will be available for 90 days following the event. Please connect to the Company's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About SGX Pharmaceuticals

SGX Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics. The SGX oncology pipeline includes drug candidates from its FAST(TM) drug discovery platform, such as SGX523, a cMET kinase inhibitor currently in Phase 1 clinical studies, next generation BCR-ABL inhibitors being developed by SGX and in partnership with Novartis, and JAK2 inhibitors. More information on the pipeline and drug discovery platform can be found at http://www.sgxpharma.com and in the Company's various filings with the Securities and Exchange Commission.


'/>"/>
SOURCE SGX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
2. Memory Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
3. MiddleBrook Pharmaceuticals to Present at BIO CEO & Investor Conference 2008
4. Celator(R) Pharmaceuticals to Present at 10th Annual BIO CEO and Investor Conference
5. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
6. Anthera Pharmaceuticals Forms Scientific Advisory Board
7. Vion Pharmaceuticals Adds William Hahne, M.D. to Senior Management Team
8. Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
9. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 5, 2008 in New York
10. Amylin Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
11. Koronis Pharmaceuticals Announces Appointment of Daniel H. Petree and George R. Painter, Ph.D. to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... MA (PRWEB) , ... June 23, 2016 , ... ... Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute ... platform of microbial tests introduced last year,” stated Bob Salter, Vice President of ...
(Date:6/23/2016)... FRANCISCO , June 23, 2016   EpiBiome ... has secured $1 million in debt financing from Silicon ... ramp up automation and to advance its drug development ... its new facility. "SVB has been an ... beyond the services a traditional bank would provide," said ...
(Date:6/23/2016)... , ... June 23, 2016 , ... In a new ... in Denmark detail how a patient who developed lymphedema after being treated for breast ... results could change the paradigm for dealing with this debilitating, frequent side effect of ...
(Date:6/23/2016)... -- Andrew D Zelenetz , ... Published recently in Oncology & ... Andrew D Zelenetz , discusses the fact ... placing an increasing burden on healthcare systems worldwide, ... the patents on many biologics expiring, interest in ...
Breaking Biology Technology:
(Date:6/2/2016)... 2016 The Department of Transport Management ... 44 million US Dollar project, for the , ... Personalization, Enrolment, and IT Infrastructure , to ... and implementation of Identity Management Solutions. Numerous renowned international vendors ... Decatur was selected for the most compliant and ...
(Date:5/24/2016)... patient care by providing unparalleled technology to leaders of the medical imaging industry.  As ... added to the range of products distributed by Ampronix. Photo - ... ... ... ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
Breaking Biology News(10 mins):